Open Save New
FeedNavigator / National Library of Health Sciences

»My Articles

»Latest Feeds

»Popular Feeds
Search Feed Catalog by Name:

Medicinal chemistry of antimigraine drugs.Current Medicinal Chemistry50 dayssaveRefWorksSFX Info
Subthreshold laser therapy for diabetic macular edema: metabolic and safety issues.Current Medicinal Chemistry50 dayssaveRefWorksSFX Info
Mitochondria damage in the pathogenesis of diabetic retinopathy and in the metabolic memory associated with its continued progression.Current Medicinal Chemistry50 dayssaveRefWorksSFX Info
Mimicking microvascular alterations of human diabetic retinopathy: a challenge for the mouse models.Current Medicinal Chemistry50 dayssaveRefWorksSFX Info
Neurodegeneration in the pathogenesis of diabetic retinopathy: molecular mechanisms and therapeutic implications.Current Medicinal Chemistry50 dayssaveRefWorksSFX Info
Fenofibrate: a new treatment for diabetic retinopathy. Molecular mechanisms and future perspectives.Current Medicinal Chemistry50 dayssaveRefWorksSFX Info
Advanced glycation end products and diabetic retinopathy.Current Medicinal Chemistry50 dayssaveRefWorksSFX Info
Somatostatin replacement: a new strategy for treating diabetic retinopathy.Current Medicinal Chemistry50 dayssaveRefWorksSFX Info
Traditional and novel risk factors of diabetic retinopathy and research challenges.Current Medicinal Chemistry50 dayssaveRefWorksSFX Info
Pericyte loss in diabetic retinopathy: mechanisms and consequences.Current Medicinal Chemistry50 dayssaveRefWorksSFX Info
Development of therapeutics for high grade gliomas using orthotopic rodent models.Current Medicinal Chemistry50 dayssaveRefWorksSFX Info
Hypoxia inducible factor stabilization as a novel strategy to treat anemia.Current Medicinal Chemistry90 dayssaveRefWorksSFX Info
Pharmacological inhibition of protein tyrosine phosphatase 1B: a promising strategy for the treatment of obesity and type 2 diabetes mellitus.Current Medicinal Chemistry90 dayssaveRefWorksSFX Info
Nanoparticles loaded with Nutlin-3 display cytotoxicity towards p53(wild-type) JVM-2 but not towards p53(mutated) BJAB leukemic cells.Current Medicinal Chemistry90 dayssaveRefWorksSFX Info
Capsaicin and its analogues: structure-activity relationship study.Current Medicinal Chemistry90 dayssaveRefWorksSFX Info
Chymase inhibition attenuates monocrotaline-induced sinusoidal obstruction syndrome in hamsters.Current Medicinal Chemistry90 dayssaveRefWorksSFX Info
Medicinal agents and metabolic syndrome.Current Medicinal Chemistry90 dayssaveRefWorksSFX Info
Flavonoids in atherosclerosis: an overview of their mechanisms of action.Current Medicinal Chemistry90 dayssaveRefWorksSFX Info
Trypanosomatidae diseases: from the current therapy to the efficacious role of trypanothione reductase in drug discovery.Current Medicinal Chemistry90 dayssaveRefWorksSFX Info
Critical Appraisal of Ischemic Stroke Pathophysiology: Road to Cerebral Resuscitation? Part II.Current Medicinal Chemistry106 dayssaveRefWorksSFX Info
Activation of PI3K/Akt/MTOR Pathway and Dual Inhibitors of PI3K and MTOR in Endometrial Cancer.Current Medicinal Chemistry106 dayssaveRefWorksSFX Info
Targeting Drug-Resistant Prostate Cancer with Dual PI3K/MTOR Inhibition.Current Medicinal Chemistry106 dayssaveRefWorksSFX Info
IL-6 Activated JAK/STAT3 Pathway and Sensitivity to Hsp90 Inhibitors in Multiple Myeloma.Current Medicinal Chemistry106 dayssaveRefWorksSFX Info
HIF-1 Signaling in Drug Resistance to Chemotherapy.Current Medicinal Chemistry106 dayssaveRefWorksSFX Info
Four Major Factors Regulate Phosphatidylinositol 3-Kinasesignaling Pathwayin Cancers Induced by Infection of Human Papillomaviruses.Current Medicinal Chemistry106 dayssaveRefWorksSFX Info
Mechanism of Cancer Drug Resistance and the Involvement of Noncoding RNAs.Current Medicinal Chemistry106 dayssaveRefWorksSFX Info
Targeting Platinum Resistant Disease in Ovarian Cancer.Current Medicinal Chemistry106 dayssaveRefWorksSFX Info
Subfractions And Subpopulations Of Hdl: An Update.Current Medicinal Chemistry106 dayssaveRefWorksSFX Info
Chronic Kidney Disease - different role for HDL?Current Medicinal Chemistry106 dayssaveRefWorksSFX Info
New Drugs for HDL-C Disorders: the Beginning.Current Medicinal Chemistry106 dayssaveRefWorksSFX Info
Inflammation, High Density Lipoprotein and Endothelium.Current Medicinal Chemistry106 dayssaveRefWorksSFX Info
bHLHTranscription Factors Inhibitors For Cancer Therapy: General Features For InSilico Drug Design.Current Medicinal Chemistry106 dayssaveRefWorksSFX Info
Role of Cardiolipin in Mitochondrial Diseases and Apoptosis.Current Medicinal Chemistry106 dayssaveRefWorksSFX Info
New Insight into Lipid Disorders.Current Medicinal Chemistry141 dayssaveRefWorksSFX Info
Cardiovascular Drug Therapy in Paediatric Age: from Metabolomics to Clinical Practice.Current Medicinal Chemistry141 dayssaveRefWorksSFX Info
Prevention of Microbial Biofilms - the Contribution of Micro and Nanostructured Materials.Current Medicinal Chemistry141 dayssaveRefWorksSFX Info
Tumor-Induced Alterations in Lipid Metabolism.Current Medicinal Chemistry141 dayssaveRefWorksSFX Info
Role of sex hormone estrogen in prevention of lipid disorder.Current Medicinal Chemistry141 dayssaveRefWorksSFX Info
Metabolic Effects of Bile Acids in the Gut in Health and Disease.Current Medicinal Chemistry141 dayssaveRefWorksSFX Info
Cholesterol Homeostasis Failure in the Brain: Implications for Synaptic Dysfunction and Cognitive Decline.Current Medicinal Chemistry141 dayssaveRefWorksSFX Info
Neuroprotective Properties of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) and its Lipid Ligands.Current Medicinal Chemistry141 dayssaveRefWorksSFX Info
Multi-Targeted Drug Design Approaches for Multifactorial Diseases: from Neurodegenerative to Cardiovascular Applications.Current Medicinal Chemistry141 dayssaveRefWorksSFX Info
PDZ Domain-Mediated Protein Interactions: Therapeutic Targets in Neurological Disorders.Current Medicinal Chemistry141 dayssaveRefWorksSFX Info
High-Density Lipoprotein, Vascular Risk, Cancer and Infection: a Case of Quantity and Quality?Current Medicinal Chemistry141 dayssaveRefWorksSFX Info
Atherogenic Versus Non-Atherogenic Lipoprotein Profiles in Healthy Individuals. Is there a Need to Change our Approach to Diagnosing Dyslipidemia?Current Medicinal Chemistry141 dayssaveRefWorksSFX Info
Metabolism of HDL and its Regulation.Current Medicinal Chemistry141 dayssaveRefWorksSFX Info
Can We Change the Functionality of HDL Cholesterol with Non-Pharmacological and Pharmacological Agents?Current Medicinal Chemistry141 dayssaveRefWorksSFX Info
Genetic Determinants of HDL Metabolism.Current Medicinal Chemistry141 dayssaveRefWorksSFX Info
Heart Failure Pharmacotherapy: Differences Between Adult and Paediatric Patients.Current Medicinal Chemistry141 dayssaveRefWorksSFX Info
Antihypertensive Therapy in Children: Differences in Medical Approach Between the United States and Europe.Current Medicinal Chemistry141 dayssaveRefWorksSFX Info
 XML / RSS feed
 « prev   page 2    next »